Duisburg, July 14, 2026. In its current outlook for fiscal year 2026, the Executive Board of PCC SE expects growth in consolidated revenue and earnings. This is due to the upward trend that has persisted since March, particularly in the chemicals segments, with production facilities operating at near full capacity and a positive outlook for the full year. <\/p>\n
The PCC Executive Board now anticipates revenue growth of 5% to 10% to nearly \u20ac1 billion. In its previous outlook, PCC had expected growth of 2% to 5%. For earnings before interest, taxes, depreciation, and amortization (EBITDA), PCC expects an increase of over 20% to a three-digit million amount, excluding one-time effects, whereas previously EBITDA was expected to remain at the prior-year level. For earnings before interest and taxes (EBIT), the current outlook for the fiscal year projects a profit. Last year, write-downs on production facilities led to a loss. <\/p>\n
Second-Quarter Outlook<\/strong><\/p>\n For the second quarter, the PCC Executive Board expects significant revenue growth, increases across all earnings metrics, and improved operating cash flow\u2014both compared to the previous quarter and to the second quarter of the prior year. The quarterly results are scheduled to be released on August 20, 2026. <\/p>\n Surge in Demand from Europe and North America<\/strong><\/p>\n This positive business performance is primarily due to the consistently strong order book in the PCC Group\u2019s chemical segments since the outbreak of the Iran War in March. Demand from European and North American customers, in particular, has increased significantly, as PCC\u2014a chemical producer with a strong production base in Europe\u2014ensures a high level of supply reliability. As a result, plant capacity utilization has risen in recent months, reaching nearly full capacity. On the earnings side, it is positive that the increase in raw material prices has so far been passed on largely through sales prices. According to the PCC Executive Board, this trend is expected to continue for the remainder of the year. <\/p>\n Countercyclical Investment Strategy<\/strong><\/p>\n \u201cWe are benefiting from the investment decisions made in recent years; the expansion of our core activities is now bearing its first fruits,\u201d explains Dr. Peter Wenzel, CEO of PCC SE. Dr. Wenzel notes that the European chemical industry as a whole is under pressure from high raw material and energy costs as well as from dumping by competitors, particularly from China. \u201cWe are countering this with our countercyclical investment strategy and strengthening our market position in chemicals and logistics.\u201d In 2025 and 2026, PCC commissioned new facilities for the production of chlorine and surfactants at its Polish sites and is also constructing a complex for the production of alkoxylates (nonionic surfactants and polyether polyols) at the PCC Group\u2019s main production site in Brzeg Dolny, Poland. In the logistics sector, PCC is building a new intermodal terminal in southeastern Poland to further expand its position as the Polish market leader in intermodal transport. <\/p>\n","protected":false},"excerpt":{"rendered":" Current Outlook: EBITDA of Over \u20ac100 Million and Consolidated Revenue of Just Under \u20ac1 Billion<\/p>\n","protected":false},"featured_media":17797,"template":"","class_list":["post-17799","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n